Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
A study by researchers in Immunoendocrinology at the Polish Academy of Sciences highlighted the importance of surveillance and management of these gastrointestinal issues to ensure patient comfort and adherence to treatment plans
10.1161/CIRCULATIONAHA.106.679597 11 BrainardR
Peptide sequence: trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH Chemical details include: Molecular formula: CHNOS Molecular weight: ~5135.785136 Da Key modification: N-terminal trans-3-hexenoyl group CAS number: 218949-78-1 This structure preserves full GHRH bioactivity and extends the half-life in experimental systems
Conrad M, Pratt DA
The liver benefits likely stem from glucagon receptor activation directly on hepatocytes (liver cells)
Phase 2 trial doses ranged from 1 mg to 12 mg once weekly
US$ 22.90
US$ 28.51
US$ 27.48
US$ 27.25
US$ 20.30
